StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) AdCom on Brodalumab Begins
July 19, 2016 8:10 AM
Valeant Pharma (NYSE: VRX) FDA advisory committee ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Next Articles
Valeant Pharma (VRX) Announces FDA AdCom Recommendation of Brodalumab as Plaque Psoriasis Treatment
July 19, 2016 4:29 PM
Mizuho Wants "to Get More Constructive" on Valeant Pharma (VRX)
July 18, 2016 6:27 AM
Valeant Pharma (VRX): Brodalumab Suicide Rate is 3-4x Higher Than Other Biologics - Mizuho
July 15, 2016 9:18 AM
Valeant Pharma (VRX) Brodalumab Briefing Docs Posted; Concerns Linger
July 15, 2016 8:10 AM
